*Some Market data delayed by 15 mins.

Aldeyra Therapeutics, Inc.

Symbol: ALDX (NASDAQ)
3.88 ▲ (6.59%) 0.240

Company Description:
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

Key Stats
  • Today's Open: $3.7
  • Today's High: $3.94
  • Today's Low: $3.605
  • Today's Volume: 320.19K
  • Yesterday Close: $3.64
  • Yesterday High: $3.71
  • Yesterday Low: $3.42
  • Yesterday Volume: 326.24K
  • Last Min Volume: 0
  • Last Min High: $3.88
  • Last Min Low: $3.88
  • Last Min VWAP: $0
Company Profile
  • Name: Aldeyra Therapeutics, Inc.
  • Website: https://www.aldeyra.com
  • Listed Date: 2014-05-02
  • Location: LEXINGTON, MA
  • Market Status: Active
  • CIK Number: 0001341235
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $229.34M
  • Round Lot: 100
  • Outstanding Shares: 59.41M
  • Asset Type: CS
RECENT FILINGS FOR ALDX
Filing DateFiling TypeFormat
2024-06-208-KView
2024-06-138-KView
2024-06-078-KView
2024-06-064View
2024-06-064View
2024-06-064View
2024-06-064View
2024-06-064View
2024-06-064View
2024-05-0210-QView
2024-04-258-KView
2024-04-24EFFECTView
2024-04-22CORRESPView
2024-04-22ARSView
2024-04-22DEFA14AView
2024-04-22DEF 14AView
2024-04-174/AView
2024-04-174/AView
2024-04-084View
2024-04-034View
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.